Financials
Financial year 2025
FEVERY PHARMA from Brugge, company number BE0552675811, closed financial year 2025 with a result of € 160,584 after tax. For that financial year FEVERY PHARMA recorded a gross margin of € 166,477 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 96,258 to € 160,584. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
€ 1.2 million
▲ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today. At incorporation the founders contributed € 227,306 in kind: shares or other assets, valued in the deed.
€ 160,584
▲ 67% vs 2024
Profit after tax over the fiscal year.
€ 225,795
▲ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 126,666 paid out
79 % of the profit went to the shareholders, the rest stayed in the company.
Debts at end 2025
€ 50,000
▼ 33% vs 2024
Loans from banks and other lenders, long and short.
€ 3,826
▲ 209% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 32,984
▲ € 25,307 vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 164,105 | € 163,600 | € 157,802 | € 166,477 | ▲ 5% |
| Profit after taxes | € 347,163 | € 96,651 | € 96,258 | € 160,584 | ▲ 67% |
| Equity | € 988,439 | € 1,070,090 | € 1,145,097 | € 1,179,015 | ▲ 3% |
| Total debts | € 696,079 | € 596,706 | € 359,642 | € 324,187 | ▼ 10% |
| Cash | € 160,040 | € 383,066 | € 178,396 | € 225,795 | ▲ 27% |
| Retained profit | € 761,132 | € 842,783 | € 917,791 | € 951,709 | ▲ 4% |
| Dividend | € 10,750 | € 15,000 | € 21,250 | € 126,666 | ▲ € 105,416 |
| Bank debt | € 158,691 | € 103,267 | € 75,000 | € 50,000 | ▼ 33% |
| Balance sheet total | € 1,684,517 | € 1,666,796 | € 1,504,740 | € 1,503,202 |
By gross margin, FEVERY PHARMA ranks 42nd of 155 companies with main activity “Activiteiten van holdings” in Brugge that publish figures (fiscal year 2025).
Key figures of FEVERY PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about FEVERY PHARMA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to FEVERY PHARMA?
What happened at FEVERY PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 160,584 (▲ 67% vs 2024). Source: NBB ↗
- Sofie Monbaliu became a director. NBB
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 347,163 profit in 2022 to € 160,584 profit in 2025.
Paid € 169,347 in corporate taxes since 2022.
Best year ever: 2022, with € 347,163 profit.
Paid out € 173,666 in dividends to the owners in total.
Management
Behind FEVERY PHARMA are Wouter Fevery and Sofie Monbaliu. It owns 99.6% of Fevery-Dewitte itself.
Directors
According to the 2025 annual accounts
Sofie Monbaliu
Director
since 2021
Establishments
Establishment units
Physical locations of this company
Zuidzandstraat 1
8000 Brugge
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Brugge
Same main activity (Activiteiten van holdings), 207 active companies in Brugge, largest first.
€ 15.1 million revenue · 2025
€ 6.6 million revenue · 2025
€ 5.4 million revenue · 2025
€ 3.3 million gross margin · 2025
€ 2.4 million revenue · 2025
€ 1.5 million gross margin · 2025
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Website info
Features
Security
Network
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Wouter Clement Roger FEVERY(oprichter) 100%
Details
- Company number
- 0552.675.811
- VAT number
- BE 0552.675.811
- Registered office
- Zuidzandstraat 1, 8000 Brugge
- Names & denominations
- FEVERY PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 May 2014
- Peppol
- Active · Active since 5 Sept 2025
- Contact
- apotheekfevery.be
- Activities · NACE
Activiteiten van holdings
Holdings
Vermogensbeheer